The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: FDASM

FDA Meeting on the Internet, Social Media and Online Drug Marketing

Following some perplexing moves by the FDA, including cracking down on Google search ads, the agency convened a two-day hearing on the use of the internet and social media for online drug marketing last week.  The goal of the hearings was to seek comments from

“all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, Internet vendors, advertising agencies, and the regulated industry … [in order to] help guide FDA in making policy decisions on the promotion of human and animal prescription drugs and biologics and medical devices using the Internet and social media tools.”

If you are interested in the topic, you can:

  1. Watch the whole thing via an archived webcast (until they take it down, but then you can read the transcript);
  2. Search #FDASM on Twitter and read the real-time reactions; or
  3. Read yesterday’s genius FiercePharma post by Tracy Staton that boils the whole thing down to a delicious executive-summary-type bite-size blurb. [See what I did there, FiercePharma headline writers?]

I highly recommend #3.

The FDA is collecting comments until February 28th (2010), after which it will digest the whole lot of them and formulate some guidance (likely) or regs (less likely) that will shape online behaviour.

P.S. Thanks LogoTwitter!

Bookmark and Share

Follow

Get every new post delivered to your Inbox.

Join 131 other followers